Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Stocker

Showing results (171-180 of 212) with videos related to

Pageof 22
Sort By:
British Journal of Clinical Pharmacology|February 15, 2024
The development and evaluation of dose-prediction tools for allopurinol therapy (Easy-Allo tools)Daniel F B Wright, Hailemichael Z Hishe, Sophie L Stocker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1990
Phase II trial of intermittent high-dose recombinant interferon alfa-2a in mycosis fungoides and the Sézary syndromeE C Kohn, R G Steis, E A Sausville, et al.
Blood|June 25, 1992
Prognostic implications of evaluation for lymph node involvement by T-cell antigen receptor gene rearrangement in mycosis fungoidesJ W Lynch, I Linoilla, E A Sausville, et al.
Molecular Pharmaceutics|December 28, 2012
Gene expression profiling of transporters in the solute carrier and ATP-binding cassette superfamilies in human eye substructuresAmber Dahlin, Ethan Geier, Sophie L Stocker, et al.
Diabetes, Obesity & Metabolism|April 15, 2024
Geographic variation in sodium-glucose cotransporter 2 inhibitor and glucagon-like peptide-1 receptor agonist use in people with type 2 diabetes in New South Wales, AustraliaJuliana de Oliveira Costa, Jialing Lin, Tamara Y Milder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Phase II trial of fludarabine phosphate and interferon alfa-2a in advanced mycosis fungoides/Sézary syndromeF M Foss, D C Ihde, I R Linnoila, et al.
The New England Journal of Medicine|December 28, 1989
A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoidesF J Kaye, P A Bunn, S M Steinberg, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 17, 2020
Towards precision dosing of vancomycin in critically ill patients: an evaluation of the predictive performance of pharmacometric models in ICU patientsC B Cunio, D W Uster, J E Carland, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|December 8, 2018
Variation in outcome reporting in randomized controlled trials of interventions for prevention and treatment of fetal growth restrictionR Townsend, F Sileo, L Stocker, et al.
Bioorganic & Medicinal Chemistry|April 25, 2016
N,N-Bis(glycityl)amines as anti-cancer drugsCharlotte L Waghorne, Hilary M Corkran, Alex A Hunt-Painter, et al.
Pageof 22

Showing results (171-180 of 212) with videos related to

Sort By:
Pageof 22
British Journal of Clinical Pharmacology|February 15, 2024
The development and evaluation of dose-prediction tools for allopurinol therapy (Easy-Allo tools)Daniel F B Wright, Hailemichael Z Hishe, Sophie L Stocker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1990
Phase II trial of intermittent high-dose recombinant interferon alfa-2a in mycosis fungoides and the Sézary syndromeE C Kohn, R G Steis, E A Sausville, et al.
Blood|June 25, 1992
Prognostic implications of evaluation for lymph node involvement by T-cell antigen receptor gene rearrangement in mycosis fungoidesJ W Lynch, I Linoilla, E A Sausville, et al.
Molecular Pharmaceutics|December 28, 2012
Gene expression profiling of transporters in the solute carrier and ATP-binding cassette superfamilies in human eye substructuresAmber Dahlin, Ethan Geier, Sophie L Stocker, et al.
Diabetes, Obesity & Metabolism|April 15, 2024
Geographic variation in sodium-glucose cotransporter 2 inhibitor and glucagon-like peptide-1 receptor agonist use in people with type 2 diabetes in New South Wales, AustraliaJuliana de Oliveira Costa, Jialing Lin, Tamara Y Milder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Phase II trial of fludarabine phosphate and interferon alfa-2a in advanced mycosis fungoides/Sézary syndromeF M Foss, D C Ihde, I R Linnoila, et al.
The New England Journal of Medicine|December 28, 1989
A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoidesF J Kaye, P A Bunn, S M Steinberg, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 17, 2020
Towards precision dosing of vancomycin in critically ill patients: an evaluation of the predictive performance of pharmacometric models in ICU patientsC B Cunio, D W Uster, J E Carland, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|December 8, 2018
Variation in outcome reporting in randomized controlled trials of interventions for prevention and treatment of fetal growth restrictionR Townsend, F Sileo, L Stocker, et al.
Bioorganic & Medicinal Chemistry|April 25, 2016
N,N-Bis(glycityl)amines as anti-cancer drugsCharlotte L Waghorne, Hilary M Corkran, Alex A Hunt-Painter, et al.
Pageof 22